[go: up one dir, main page]

MX2018000570A - Nuevas isoformas de tripsina y su uso. - Google Patents

Nuevas isoformas de tripsina y su uso.

Info

Publication number
MX2018000570A
MX2018000570A MX2018000570A MX2018000570A MX2018000570A MX 2018000570 A MX2018000570 A MX 2018000570A MX 2018000570 A MX2018000570 A MX 2018000570A MX 2018000570 A MX2018000570 A MX 2018000570A MX 2018000570 A MX2018000570 A MX 2018000570A
Authority
MX
Mexico
Prior art keywords
isoforms
novel trypsin
trypsin isoforms
novel
trypsin
Prior art date
Application number
MX2018000570A
Other languages
English (en)
Other versions
MX390126B (es
Inventor
Gudmundsdottir Agusta
Asgeirsson Asgeir
Stefansson Bjarki
Original Assignee
Enzymatica Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53758073&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2018000570(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Enzymatica Ab filed Critical Enzymatica Ab
Publication of MX2018000570A publication Critical patent/MX2018000570A/es
Publication of MX390126B publication Critical patent/MX390126B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/6408—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1706—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21004—Trypsin (3.4.21.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Pulmonology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Tropical Medicine & Parasitology (AREA)

Abstract

La presente invención se refiere a nuevas isoformas de tripsina ZT. En particular, la invención se refiere al uso de isoformas de tripsina ZT en dispositivos médicos, productos farmacéuticos y cosméticos.
MX2018000570A 2015-07-24 2016-07-22 Nuevas isoformas de tripsina y su uso. MX390126B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15178208.3A EP3121272A1 (en) 2015-07-24 2015-07-24 Novel fish trypsin isoforms and their use
PCT/EP2016/067531 WO2017017012A1 (en) 2015-07-24 2016-07-22 Novel trypsin isoforms and their use

Publications (2)

Publication Number Publication Date
MX2018000570A true MX2018000570A (es) 2018-08-09
MX390126B MX390126B (es) 2025-03-20

Family

ID=53758073

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018000570A MX390126B (es) 2015-07-24 2016-07-22 Nuevas isoformas de tripsina y su uso.

Country Status (19)

Country Link
US (2) US11179311B2 (es)
EP (3) EP3121272A1 (es)
JP (2) JP6869979B2 (es)
KR (1) KR20180032588A (es)
CN (2) CN113846079B (es)
AU (1) AU2016299760B2 (es)
BR (1) BR112018001404A2 (es)
CA (1) CA2992821A1 (es)
DK (3) DK3325618T3 (es)
ES (1) ES2813551T3 (es)
HR (1) HRP20201290T1 (es)
HU (1) HUE050121T2 (es)
MX (1) MX390126B (es)
PL (1) PL3325618T3 (es)
PT (1) PT3325618T (es)
RS (1) RS60711B1 (es)
RU (1) RU2739945C2 (es)
SI (1) SI3325618T1 (es)
WO (1) WO2017017012A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3387844B2 (ja) 1999-01-29 2003-03-17 株式会社ノダ 幅木材と床材の納まり構造
EP3121272A1 (en) 2015-07-24 2017-01-25 Zymetech ehf. Novel fish trypsin isoforms and their use
GB201701315D0 (en) 2017-01-26 2017-03-15 Enzymatica Ab Novel treatments
CA3087228A1 (en) * 2017-12-28 2019-07-04 Consegna Pharma Inc. Long acting opioid antagonists
GB201800274D0 (en) 2018-01-08 2018-02-21 Enzymatica Ab Novel treatments
GB201801982D0 (en) 2018-02-07 2018-03-28 Enzymatica Ab Novel treatments
EP3969579A1 (en) * 2019-05-13 2022-03-23 Bioseutica B.V. Purified fish proteases with high specific activities and its process of production
US11441261B2 (en) 2020-09-10 2022-09-13 WABESO Enhanced Enzymatics, Inc. Self-sterilizing fabrics incorporating anti-viral cold-active proteases
CN117794513A (zh) * 2021-08-03 2024-03-29 智密科技公司 用于治疗上呼吸道微生物感染的肽酶制剂
WO2024044679A2 (en) * 2022-08-24 2024-02-29 Ohio State Innovation Foundation Methods of synthesizing peptides with free n-terminal cysteine and products thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59501908A (ja) 1982-10-25 1984-11-15 ヘルグレン・ラルス・グスタ−ヴ・インゲ クリーニング用酵素組成物
SE8302268L (sv) 1983-04-22 1984-10-23 Lars G I Hellgren Ny kombination av proteolytiska och lipolytiska enzymer lemplig som tvettkomposition
SE454566B (sv) 1984-04-24 1988-05-16 Lars G I Hellgren Farmaceutisk komposition innehallande en verksam mengd av vattenlosliga proteinaser som extraherats fran ett vattenlevande djur valt av ordningen euphausiaceae eller slektet mallotus
JPS6130527A (ja) 1984-07-20 1986-02-12 Kao Corp 血栓溶解剤
US6030612A (en) 1994-11-22 2000-02-29 Phairson Medical Inc. Antimicrobial uses of multifunctional enzyme
DE60014659T2 (de) 1999-06-18 2006-03-02 Jon Bragi Bjarnason Pharmazeutische- und kosmetischezusammensetzungen enthaldend serinproteasen aus kabeljau und deren pharmazeutische und kosmetische verwendung
RU2286171C1 (ru) 2005-04-12 2006-10-27 Эдуард Артемович Макарян Препарат для профилактики и лечения респираторных и желудочно-кишечных инфекционных заболеваний бактериальной и вирусной этиологии сельскохозяйственных животных и способ профилактики и лечения респираторных и желудочно-кишечных инфекционных заболеваний бактериальной и вирусной этиологии сельскохозяйственных животных
CA2656531C (en) * 2006-07-05 2012-12-11 Catalyst Biosciences, Inc. Protease screening methods and proteases identified thereby
CN101250574A (zh) * 2007-03-22 2008-08-27 中国海洋大学 一种梯级分子量鳕鱼鱼皮胶原肽的制备方法
WO2011063394A2 (en) 2009-11-23 2011-05-26 Olmstead Stephen F Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
GB0921288D0 (en) * 2009-12-04 2010-01-20 Health Prot Agency Therapies for preventing or suppressing clostridium difficile infection
CA3075772C (en) 2011-05-31 2022-07-19 Hutchison Biofilm Medical Solutions Limited Dispersion and detachment of cell aggregates
CN102228126B (zh) * 2011-06-10 2013-03-13 天津市虎豹调味品酿造有限公司何庄分公司 一种鳕鱼骨水解蛋白液的制备方法
CN103320485B (zh) * 2013-06-03 2015-12-23 王南平 一种医用级生物材料用鱼皮胶原的制备方法
EP3121272A1 (en) * 2015-07-24 2017-01-25 Zymetech ehf. Novel fish trypsin isoforms and their use

Also Published As

Publication number Publication date
RS60711B1 (sr) 2020-09-30
CN113846079A (zh) 2021-12-28
CN107849551B (zh) 2021-11-02
SI3325618T1 (sl) 2020-12-31
WO2017017012A1 (en) 2017-02-02
RU2739945C2 (ru) 2020-12-30
DK201870049A1 (en) 2018-02-05
KR20180032588A (ko) 2018-03-30
DK180405B1 (en) 2021-04-14
EP3736331A1 (en) 2020-11-11
AU2016299760A1 (en) 2018-02-01
EP3325618A1 (en) 2018-05-30
EP3325618B1 (en) 2020-05-27
PL3325618T3 (pl) 2020-11-16
PT3325618T (pt) 2020-09-04
DK181080B1 (en) 2022-11-29
HRP20201290T1 (hr) 2020-11-13
CA2992821A1 (en) 2017-02-02
CN113846079B (zh) 2024-12-03
HUE050121T2 (hu) 2020-11-30
JP7116823B2 (ja) 2022-08-10
DK3325618T3 (da) 2020-08-10
BR112018001404A2 (pt) 2018-09-11
RU2018106533A (ru) 2019-08-26
MX390126B (es) 2025-03-20
RU2018106533A3 (es) 2020-01-30
AU2016299760B2 (en) 2021-11-18
US20200197288A1 (en) 2020-06-25
US20220062148A1 (en) 2022-03-03
DK202070808A1 (en) 2021-02-26
JP2021106603A (ja) 2021-07-29
RU2020142400A (ru) 2021-02-11
CN107849551A (zh) 2018-03-27
ES2813551T3 (es) 2021-03-24
JP2018520707A (ja) 2018-08-02
US11179311B2 (en) 2021-11-23
US11918674B2 (en) 2024-03-05
JP6869979B2 (ja) 2021-05-12
EP3121272A1 (en) 2017-01-25

Similar Documents

Publication Publication Date Title
MX2018000570A (es) Nuevas isoformas de tripsina y su uso.
BR112017011215A2 (pt) partículas de distribuição de pró-flavorizante
AU201612764S (en) Oral care implement
AU201612818S (en) Oral care implement
EA201792450A1 (ru) Матирующие косметические композиции
BR112017000456A2 (pt) composições antivirais tópicas e métodos de uso das mesmas
BR112016002391A2 (pt) composições tópicas e métodos de uso das mesmas
CO2019008103A2 (es) Composiciones farmacéuticas para terapia de combinación
MX2023006415A (es) Anticuerpos, usos y metodos.
AU201612882S (en) Oral care implement
MX386055B (es) Uso de medicamentos para disminuir la evolución de la enfermedad de parkinson.
AU201612579S (en) Oral care implement
BR112018002382A8 (pt) Novos anticorpos anti-gvpi humano e usos dos mesmos
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
EP3610851A4 (en) COMPOSITION OF SKIN CLEANSING AGENT
FR3029915B1 (fr) Tripeptides, compositions les comprenant et utilisations notamment cosmetiques
MX2017000862A (es) Formulacion de factor viii.
UY34590A (es) Fenilimidazopirazoles sustituidos y su uso
TR201905218T4 (tr) Nörodejenerati̇f hastaliklarin tedavi̇si̇ i̇çi̇n yararli vi̇tanoli̇dler.
MX2017008090A (es) Nuevos compuestos, su procedimiento de sintesis y su uso en medicina, asi como en cosmetica.
MX378868B (es) Sintesis de polioles polimericos en polioles insaturados, polioles polimericos y su uso.
DOP2015000175A (es) Uso de un péptido natriurético, un péptido diurético o un péptido vasodilatador en la elaboración de un medicamento para tratar una condición cardiovascular
MX385322B (es) Uso de sedoheptulosa para la prevención y tratamiento de inflamación.
CO2018005700A2 (es) Formulaciones de giberelina en solución concentrada
TR201819130T4 (tr) Sulu Formülasyonlar, Bunların Üretimi Ve Kullanımı